Photodynamic therapy for basal cell carcinoma

Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial

(2014) M.H. Roozeboom et al.   BRITISH JOURNAL OF DERMATOLOGY

Light Fractionation Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolaevulinic Acid Photodynamic Therapy: Five-year Follow-up of a Randomized, Prospective Trial

(2013) H Vijlder et al.   ACTA DERMATO-VENEREOLOGICA

Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma

(2013) Z. Apalla et al.   BRITISH JOURNAL OF DERMATOLOGY

Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up

(2013) Marieke H. Roozeboom et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study

(2013) S.R. Wiegell et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy

(2013) N. Basset-Seguin et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial

(2013) Aimée HMM Arits et al.   LANCET ONCOLOGY

Efficacy of photodynamic therapy for treatment of basal cell carcinoma in organ transplant recipients

(2013) N. J. Collier et al.   LASERS IN MEDICAL SCIENCE

Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions

(2013) L. Themstrup et al.   Photodiagnosis and Photodynamic Therapy

Evaluation of Recurrence After Photodynamic Therapy with Topical Methylaminolaevulinate for 157 Basal Cell Carcinomas in 90 Patients

(2012) R Lindberg-Larsen et al.   ACTA DERMATO-VENEREOLOGICA

High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study

(2012) E. Christensen et al.   BRITISH JOURNAL OF DERMATOLOGY

Reflectance confocal microscopy allowsin vivoreal-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma

(2012) M. Venturini et al.   BRITISH JOURNAL OF DERMATOLOGY

Photodynamic therapy with intralesional photosensitizer and laser beam application: An alternative treatment for nodular basal cell carcinoma

(2012) Manuel Ángel Rodríguez-Prieto et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen’s disease, basal cell carcinoma

(2012) C.A. Morton et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma

(2012) R. Cosgarea et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study

(2012) Sally Helen Ibbotson et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

(2010) F. Fantini et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

(2009) Peter Foley et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.

(2008) RM Szeimies et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY